guest ::
| Home > Publications database > Patient- and xenograft-derived organoids recapitulate pediatric brain tumor features and patient treatments. > print |
| Home > Publications database > Patient- and xenograft-derived organoids recapitulate pediatric brain tumor features and patient treatments. > print |
| 001 | 285710 | ||
| 005 | 20240229155116.0 | ||
| 024 | 7 | _ | |a 10.15252/emmm.202318199 |2 doi |
| 024 | 7 | _ | |a pmid:38037472 |2 pmid |
| 024 | 7 | _ | |a 1757-4676 |2 ISSN |
| 024 | 7 | _ | |a 1715-4684 |2 ISSN |
| 024 | 7 | _ | |a 1757-4684 |2 ISSN |
| 024 | 7 | _ | |a altmetric:157008255 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2023-02518 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Lago, Chiara |0 0000-0002-1317-7847 |b 0 |
| 245 | _ | _ | |a Patient- and xenograft-derived organoids recapitulate pediatric brain tumor features and patient treatments. |
| 260 | _ | _ | |a Heidelberg |c 2023 |b EMBO Press |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1702389506_9552 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a #LA:B062# / 2023 Dec 7;15(12):e18199 |
| 520 | _ | _ | |a Brain tumors are the leading cause of cancer-related death in children. Experimental in vitro models that faithfully capture the hallmarks and tumor heterogeneity of pediatric brain cancers are limited and hard to establish. We present a protocol that enables efficient generation, expansion, and biobanking of pediatric brain cancer organoids. Utilizing our protocol, we have established patient-derived organoids (PDOs) from ependymomas, medulloblastomas, low-grade glial tumors, and patient-derived xenograft organoids (PDXOs) from medulloblastoma xenografts. PDOs and PDXOs recapitulate histological features, DNA methylation profiles, and intratumor heterogeneity of the tumors from which they were derived. We also showed that PDOs can be xenografted. Most interestingly, when subjected to the same routinely applied therapeutic regimens, PDOs respond similarly to the patients. Taken together, our study highlights the potential of PDOs and PDXOs for research and translational applications for personalized medicine. |
| 536 | _ | _ | |a 312 - Funktionelle und strukturelle Genomforschung (POF4-312) |0 G:(DE-HGF)POF4-312 |c POF4-312 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
| 650 | _ | 7 | |a brain tumors |2 Other |
| 650 | _ | 7 | |a organoids |2 Other |
| 650 | _ | 7 | |a patient-derived |2 Other |
| 650 | _ | 7 | |a pediatric cancer |2 Other |
| 650 | _ | 7 | |a translational applications |2 Other |
| 700 | 1 | _ | |a Federico, Aniello |0 P:(DE-He78)32c5110cd42ee8a96b18a3e8909bd0a9 |b 1 |u dkfz |
| 700 | 1 | _ | |a Leva, Gloria |0 0000-0003-1147-700X |b 2 |
| 700 | 1 | _ | |a Mack, Norman L |0 P:(DE-He78)e73a0a4fab40344d89d693cbe1df3109 |b 3 |u dkfz |
| 700 | 1 | _ | |a Schwalm, Benjamin |0 P:(DE-He78)9ce969bf1ac7913b3f2b1cf4dd7f823e |b 4 |u dkfz |
| 700 | 1 | _ | |a Ballabio, Claudio |0 0000-0001-6632-1489 |b 5 |
| 700 | 1 | _ | |a Gianesello, Matteo |0 0000-0002-8976-6883 |b 6 |
| 700 | 1 | _ | |a Abballe, Luana |b 7 |
| 700 | 1 | _ | |a Giovannoni, Isabella |0 0000-0002-9980-6594 |b 8 |
| 700 | 1 | _ | |a Reddel, Sofia |b 9 |
| 700 | 1 | _ | |a Rossi, Sabrina |b 10 |
| 700 | 1 | _ | |a Leone, Nicolas |0 0000-0003-1494-5411 |b 11 |
| 700 | 1 | _ | |a Carai, Andrea |b 12 |
| 700 | 1 | _ | |a Mastronuzzi, Angela |b 13 |
| 700 | 1 | _ | |a Bisio, Alessandra |0 0000-0002-3326-1923 |b 14 |
| 700 | 1 | _ | |a Soldano, Alessia |0 0000-0002-3120-9929 |b 15 |
| 700 | 1 | _ | |a Quintarelli, Concetta |b 16 |
| 700 | 1 | _ | |a Locatelli, Franco |0 0000-0002-7976-3654 |b 17 |
| 700 | 1 | _ | |a Kool, Marcel |0 P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8 |b 18 |e Last author |u dkfz |
| 700 | 1 | _ | |a Miele, Evelina |0 0000-0002-4747-1032 |b 19 |
| 700 | 1 | _ | |a Tiberi, Luca |0 0000-0002-5983-3782 |b 20 |
| 773 | _ | _ | |a 10.15252/emmm.202318199 |g p. e18199 |0 PERI:(DE-600)2485479-7 |n 12 |p e18199 |t EMBO molecular medicine |v 15 |y 2023 |x 1757-4676 |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:285710 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-He78)32c5110cd42ee8a96b18a3e8909bd0a9 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)e73a0a4fab40344d89d693cbe1df3109 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 4 |6 P:(DE-He78)9ce969bf1ac7913b3f2b1cf4dd7f823e |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 18 |6 P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-312 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Funktionelle und strukturelle Genomforschung |x 0 |
| 914 | 1 | _ | |y 2023 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b EMBO MOL MED : 2022 |d 2023-10-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2023-10-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2021-07-19T13:19:31Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2021-07-19T13:19:31Z |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Anonymous peer review, Double anonymous peer review |d 2021-07-19T13:19:31Z |
| 915 | _ | _ | |a Creative Commons Attribution CC BY (No Version) |0 LIC:(DE-HGF)CCBYNV |2 V:(DE-HGF) |b DOAJ |d 2021-07-19T13:19:31Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-10-25 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2023-10-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2023-10-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2023-10-25 |
| 915 | _ | _ | |a IF >= 10 |0 StatID:(DE-HGF)9910 |2 StatID |b EMBO MOL MED : 2022 |d 2023-10-25 |
| 915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2023-10-25 |
| 915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2023-10-25 |
| 920 | 2 | _ | |0 I:(DE-He78)B062-20160331 |k B062 |l B062 Pädiatrische Neuroonkologie |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)B062-20160331 |k B062 |l B062 Pädiatrische Neuroonkologie |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)HD01-20160331 |k HD01 |l DKTK HD zentral |x 1 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)B062-20160331 |
| 980 | _ | _ | |a I:(DE-He78)HD01-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|